679 results match your criteria: "GROW-School for Oncology and Reproduction[Affiliation]"
Br J Dermatol
November 2024
Department of Dermatology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Swiss Dent J
November 2024
Klinik für Mund-, Kiefer- und Gesichtschirurgie - Poliklinik für Oralchirurgie, Zentrum für Zahnmedizin, Universität Zürich.
Cervical lymphadenopathy can indicate a range of diseases, including infections, inflammation, and neoplastic processes. Accurate diagnosis is crucial for identifying the underlying cause and determining appropriate treatment. Diagnostic procedures include clinical examination, ultrasound, fine needle aspiration, biopsy, and imaging techniques.
View Article and Find Full Text PDFESMO Open
November 2024
Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address:
Purpose: Molecular tumor boards (MTBs) are considered beneficial for treatment decision making for patients with cancer with uncommon, rare, or complex mutational profiles. The lack of international MTB guidelines results in significant variation in practices and recommendations. Therefore, periodic follow-up is necessary to assess and govern MTB functioning.
View Article and Find Full Text PDFInt J Cancer
March 2025
Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands.
J Plast Reconstr Aesthet Surg
December 2024
Nivel, Utrecht, the Netherlands; Tranzo, Tilburg School of Social Sciences and Behavioral Research, Tilburg University, Tilburg, the Netherlands.
Background: There has been a growing concern about a possible causal relationship between silicone breast implants (SBIs) and health symptoms, referred to as breast implant illness. This study assessed the association between SBIs for cosmetic augmentation and health symptoms.
Methods: This retrospective cohort study used the data from the Dutch Breast Implant Registry and Nivel Primary Care Database.
Injury
November 2024
Department of Trauma Surgery, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands; Department of Surgery, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
Introduction: The diagnosis of low-grade infection in post-traumatic long bone non-unions poses challenges due to the absence of clinical signs. This study aimed to review the available literature on the diagnostic accuracy of imaging techniques for low-grade infections and assess the diagnostic accuracy of F-FDG PET-CT scans for low-grade infection in post-traumatic long bone non-unions.
Methods: A mini-review was conducted using Pubmed in March 2024.
Hum Reprod
December 2024
Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands.
Study Question: What are the reproductive outcomes of patients who cryopreserved oocytes or embryos in the context of fertility preservation in the Netherlands?
Summary Answer: This study shows that after a 10-year follow-up period, the utilization rate to attempt pregnancy using cryopreserved oocytes or embryos was 25.5% and the cumulative live birth rate after embryo transfer was 34.6% per patient.
APMIS
January 2025
Department of Imaging and Pathology, Laboratory of Translational Cell and Tissue Research, KU Leuven - University of Leuven, Leuven, Belgium.
Phyllodes tumors (PTs) are rare breast tumors showing overlapping features with fibroadenomas (FAs). Diagnosis on small biopsies is challenging. New diagnostic markers are needed.
View Article and Find Full Text PDFJ Pathol Clin Res
November 2024
Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
In recent years, it has become clear that artificial intelligence (AI) models can achieve high accuracy in specific pathology-related tasks. An example is our deep-learning model, designed to automatically detect serous tubal intraepithelial carcinoma (STIC), the precursor lesion to high-grade serous ovarian carcinoma, found in the fallopian tube. However, the standalone performance of a model is insufficient to determine its value in the diagnostic setting.
View Article and Find Full Text PDFClin Cancer Res
January 2025
Cancer Medicine Department, Gustave Roussy, Villejuif, France.
Radiology
October 2024
From the Departments of Epidemiology (D.Z., G.S., G.H.d.B., M.A.H.), Radiology (G.S., M.P., R.V.), and Pulmonary Disease (H.J.M.G.), University of Groningen, University Medical Center Groningen, Hanzeplein 1, Postbus 30.001, 9700RB Groningen, the Netherlands; Department of Medical Imaging, Diagnostic Image Analysis Group, Radboud University Medical Center, Nijmegen, the Netherlands (C.J., M.P.); Department of Radiology, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands (P.A.d.J.); Department of Radiology and Nuclear Medicine, Maastricht University, Maastricht University Medical Center, Maastricht, the Netherlands (H.A.G.); GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (H.A.G.); Department of Pulmonary Medicine, University of Rotterdam, University Medical Center Rotterdam, Rotterdam, the Netherlands (R.S., J.G.A.); Department of Respiratory Oncology, University Hospitals Leuven, Leuven, Belgium (K.N.); Institute for Diagnostic Accuracy, Groningen, the Netherlands (M.A.H.); and Department of Respiratory Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands (M.A.H.).
Radiother Oncol
January 2025
Oncode Institute, Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherland; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands(2). Electronic address:
Purpose: Tumor hypoxia imposes a main obstacle to the efficacy of anti-cancer therapy. Understanding the cellular dynamics of individual hypoxic cells before, during and post-treatment has been hampered by the technical inability to identify and trace these cells over time.
Methods And Materials: Here, we present a novel lineage-tracing reporter for hypoxic cells based on the conditional expression of a HIF1a-CreER-UnaG biosensor that can visualize hypoxic cells in a time-dependent manner and trace the fate of hypoxic cells over time.
Int J Radiat Oncol Biol Phys
October 2024
Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. Electronic address:
Purpose: The value of integrating clinical variables, radiomics, and tumor-derived cell-free DNA (cfDNA) for the prediction of survival and response to chemoradiation of patients with resectable esophageal adenocarcinoma is not yet known. Our aim was to investigate if radiomics and cfDNA metrics combined with clinical variables can improve personalized predictions.
Methods And Materials: A cohort of 111 patients with resectable esophageal adenocarcinoma from 2 centers treated with neoadjuvant chemoradiation therapy was used for exploratory retrospective analyses.
medRxiv
November 2024
Department of Computational Applied Mathematics and Operations Research, Rice University, Houston, TX, USA.
Background And Purpose: Prior work on adaptive organ-at-risk (OAR)-sparing radiation therapy has typically reported outcomes based on fixed-number or fixed-interval re-planning, which represent one-size-fits-all approaches and do not account for the variable progression of individual patients' toxicities. The purpose of this study was to determine the personalized optimal timing for re-planning in adaptive OAR-sparing radiation therapy, considering limited re-planning resources, for patients with head and neck cancer (HNC).
Materials And Methods: A novel Markov decision process (MDP) model was developed to determine optimal timing of re-planning based on the patient's expected toxicity, characterized by normal tissue complication probability (NTCP), for four toxicities.
J Clin Med
October 2024
Department of Surgery, Maastricht University Medical Center, P. Debyelaan 25, GROW School for Oncology and Reproduction, Maastricht University, 6229 HX Maastricht, The Netherlands.
: A watch-and-wait strategy for patients with rectal cancer who achieve a clinical complete response after neoadjuvant (chemo) radiotherapy is a valuable alternative to rectal resection. In this pilot study, we explored the use of an electronic nose to predict response to neoadjuvant therapy by analyzing breath-derived volatile organic compounds. A pilot study was performed between 2020 and 2022 on patients diagnosed with intermediate- or high-risk rectal cancer who were scheduled for neoadjuvant therapy.
View Article and Find Full Text PDFBest Pract Res Clin Haematol
September 2024
GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center+, Maastricht, the Netherlands. Electronic address:
Br J Surg
October 2024
Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Eur J Cancer
November 2024
Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands; Department of Medical Oncology, Helse Førde, Svanehaugvegen 2, 6812 Førde, Norway. Electronic address:
Background: Adjuvant anti-PD-1 therapy improves relapse free survival in stage III melanoma, but also leads to immune-related adverse events (irAEs). Older patients are of particular interest due to comorbidities and frailty, which may impact their ability to tolerate irAEs and benefit from anti-PD-1 therapy. This study aimed to explore associations between clinical parameters and the occurrence of grade ≥ 3 irAEs and recurrence-free survival (RFS) in older patients with radically resected stage III/IV cutaneous melanoma treated with adjuvant anti-PD-1 therapy.
View Article and Find Full Text PDFColorectal Dis
November 2024
Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
Aim: In the last decade, the Netherlands has implemented various diagnostic and treatment strategies to enhance rectal cancer outcomes. This study, using data from the Prospective Dutch ColoRectal Cancer (PLCRC) cohort, investigates whether these multidisciplinary advancements have translated into improved health-related quality of life (HRQoL) and functional outcomes for the general Dutch rectal cancer population.
Methods: Patients with Stage I-III rectal cancer enrolled in the PLCRC cohort were included.
Hum Reprod
December 2024
Department of Obstetrics and Gynaecology, Centre for Reproductive Medicine, Amsterdam UMC Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
Study Question: Does offering the Pleasure&Pregnancy (P&P) programme rather than expectant management improve naturally conceived ongoing pregnancy rates in couples diagnosed with unexplained infertility?
Summary Answer: The P&P programme had no effect on the ongoing pregnancy rates of couples with unexplained infertility.
What Is Known Already: Underpowered studies suggested that face-to-face interventions targeting sexual health may increase pregnancy rates. The impact of an eHealth sexual health programme had yet to be evaluated by a large randomized controlled trial.
Clin Cancer Res
December 2024
Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Purpose: To provide patients with MET-mutated advanced non-small cell lung cancer (METmut aNSCLC) access to crizotinib, further substantiate evidence of its efficacy and safety in this setting, and find potential biomarkers for nonresponse.
Patients And Methods: In the Drug Rediscovery Protocol (NCT0295234), patients with an actionable molecular profile are treated with off-label registered drugs. Both treated and untreated patients with aNSCLC harboring MET exon 14 skipping or other MET mutations received crizotinib 250 mg BID until disease progression or intolerable toxicity.
Eur J Surg Oncol
December 2024
Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands; GROW School for Oncology and Reproduction - University of Maastricht, Maastricht, the Netherlands.
Introduction: DW-MRI is a non-invasive way to determine the peritoneal cancer index (PCI) in colorectal cancer (CRC) patients with peritoneal metastases (PM). However, like surgeons during surgery, radiologists struggle to differentiate between PM and fibrosis. This study aimed to investigate the agreement between the PCI as determined by MRI (mriPCI), during surgery (sPCI) and histopathology examination (pPCI) in CRC patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
View Article and Find Full Text PDFNat Rev Dis Primers
September 2024
Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany.
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screening of populations at risk with low-dose CT, the implementation of novel surgical and radiotherapeutic techniques and a deeper biological understanding of NSCLC that has led to innovative systemic treatment options have improved the prognosis of patients with NSCLC.
View Article and Find Full Text PDFEndoscopy
December 2024
Gastroenterology and Hepatology, Catharina Ziekenhuis, Eindhoven, Netherlands.
Background: Currently data on the risk of progression to and lifetime risk of cancer are not available for patients with young onset Barrett's esophagus (BE). Our aim was to obtain epidemiologic data on the incidence of dysplasia or adenocarcinoma in young onset BE in the Netherlands by collecting data on all histologically confirmed cases over a prolonged period of 25 years between January 1, 1991 and December 31, 2015.
Methods: Data were obtained from the Dutch National Pathology Registry.
Int J Cancer
February 2025
Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Alterations within the tryptophan-kynurenine metabolic pathway have been linked to the etiology of colorectal cancer (CRC), but the relevance of this pathway for prognostic outcomes in CRC patients needs further elucidation. Therefore, we investigated associations between circulating concentrations of tryptophan-kynurenine pathway metabolites and all-cause mortality among CRC patients. This study utilizes data from 2102 stage I-III CRC patients participating in six prospective cohorts involved in the international FOCUS Consortium.
View Article and Find Full Text PDF